Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Willow Biosciences Inc. CANSF

MissionIRNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Announces Completion of Groundbreaking Study on CBG Use on Skin

Willow Biosciences (TSX: WLLW) (OTCQX: CANSF), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates, has completed a series of studies evaluating the safety and anti-inflammatory, anti-aging, and antimicrobial properties of its cannabigerol … Continue reading

Posted in MissionIRNewsBreaks, Willow Biosciences Inc. CANSF | Leave a comment

MissionIRNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Completes 1st Commercial Scale Fermentation Run of CBG

Willow Biosciences (TSX: WLLW) (OTCQX: CANSF) today announced its completion of the first commercial scale fermentation run of its first cannabinoid for market, cannabigerol (“CBG”). “We are very pleased with the yield and quality of our first commercial scale fermentation … Continue reading

Posted in Willow Biosciences Inc. CANSF | Leave a comment

MissionIRNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Releases Q4 and FY 2020 Financial, Operational Report

Willow Biosciences (TSX: WLLW) (OTCQX: CANSF), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates, has announced its fourth-quarter and full-year numbers for the period ended Dec. 31, 2020. In the report, Willow … Continue reading

Posted in Willow Biosciences Inc. CANSF | Leave a comment

MissionIRNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Updates Status Regarding Acceleration of Expiry Date of Outstanding Warrants

Willow Biosciences (TSX: WLLW) (OTCQX: CANSF), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates, has released an update on the acceleration of common share warrants that was previously announced. Willow completed the … Continue reading

Posted in MissionIRNewsBreaks, Willow Biosciences Inc. CANSF | Leave a comment

MissionIRNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Secures $28.75M in Bought Deal Offering

Willow Biosciences (TSX: WLLW) (OTCQX: CANSF) has closed its previously announced upsized bought deal offering of 17,424,800 common shares of the company, each at a price of $1.65, including 2,272,800 common shares issued per the full exercise of the over-allotment … Continue reading

Posted in Willow Biosciences Inc. CANSF | Leave a comment